Ubiquitech Reports 279% Revenue Increase; HempLife Today Continues Its Strong Growth With Sales Revenue of Its CannazALL CBD Hemp Products in Excess of $750,000 for the 2nd Quarter of 2015

TAMPA, FL--(Marketwired - Jul 16, 2015) - Ubiquitech Software Corp. (www.ubiquitechsoftware.com) (OTC PINK: UBQU), an International Technology and Services company, that also owns the division HempLifeToday.com, is announcing that sales growth for HempLifeToday.com for the 2nd quarter ended May 31, 2015 continues to climb with gross sales of $750,513. This compares to revenues of $268,500 in the year ago quarter and represents a 279% year-over-year increase in revenues. This strong sales trend is due to the exceptional CBD hemp products offered, an aggressive marketing campaign, and superior customer support.

HempLifeToday.com™ has developed two award-winning lines of CannazALL™ CBD Oil. The first line is the purest CBD available, a domestic blend grown in Colorado which is a premium Hemp strain approved by the Colorado State Agriculture Department. The second line is a European CBD which is grown with non-GMO plants at specific latitudes in specially chosen locations of Northern Europe. HempLife Today™ offers CBD hemp products under the brand name CannazALL™ and currently offers its potent CBD oil, a flavorful Tincture, a robust Vape oil, and Combo Packs of all of their popular CBD products. With this strong lineup of exclusive products that are only available through the HempLifeToday.com Website, and the efficiency in shipping and customer support, the company expects sales to continue to climb throughout 2015 and beyond. 

"Our customers love our products and we offer the finest CBD products we know of," said Tim Zorn, CEO of HempLife Today. "We pride ourselves on our superior product, our exceptional customer support and our super fast shipping. This is the combination that gets us customers and keeps them satisfied and returning for additional purchases."  

With this announcement HempLifeToday™ continues its plans for expansion of its CannazALL™ hemp CBD Oil products and expects more news in the near future on additional marketing plans. With less than 5% of the population exposed to CBD oil and its potential health benefits the company is poised to take advantage of the growing awareness and popularity of its quality products.

"We see all good things ahead," said James Ballas, CEO of Ubiquitech. "With our combination of great products and support, and our vast knowledge of marketing, we know that HempLifeToday will continue its growth. This is why we acquired HempLifeToday and we continue to execute on our business plan."

About Ubiquitech Software Corp.

Ubiquitech Software Corp., through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries. HempLifeToday.com™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life-enriching enhancement that CBD Oil from the Hemp plant can bring. HempLifeToday.com™ has developed two award-winning lines of CannazALL™ CBD Oil. The first line is the purest CBD available, our domestic blend grown in Colorado, USA which is a premium Hemp strain approved by the Colorado State Agriculture Department. The second line is our European CBD which are grown with non-GMO plants at specific latitudes in specially chosen locations of Northern Europe.

This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.